Top compounds associated with response to TRIM16L


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA austocystin d CTRPv2 pan-cancer AAC -0.12 0.002
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.1 0.002
mRNA Topotecan CTRPv2 pan-cancer AAC -0.1 0.002
mRNA SN-38 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.1 0.002
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA compound 1B CTRPv2 pan-cancer AAC 0.12 0.003
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.099 0.003
Download CSV